¡Activa las notificaciones laborales por email!
Mejora tus posibilidades de llegar a la entrevista
Elabora un currículum adaptado a la vacante para tener más posibilidades de triunfar.
Una empresa innovadora en el campo de las medicinas genéticas busca un Científico en Desarrollo Analítico para unirse a su equipo. En este emocionante rol, serás responsable de desarrollar y validar métodos analíticos para terapias génicas, asegurando la calidad y eficacia de los tratamientos. Con un enfoque en la colaboración, trabajarás junto a equipos multidisciplinarios para enfrentar desafíos técnicos complejos y contribuir a la presentación de datos regulatorios. Si estás listo para hacer una diferencia significativa en la vida de los pacientes con enfermedades raras y deseas formar parte de un entorno dinámico donde la innovación es clave, esta es tu oportunidad.
SpliceBio is a genetic medicines company pioneering Protein Splicing to address diseases caused by mutations in large genes. SpliceBio’s lead program, SB-007, targets the root cause of Stargardt disease – a genetic eye disease that causes blindness in children and adults – and is expected to enter clinical trials in 2025.
SpliceBio’s pipeline includes additional gene therapy programs across therapeutic areas, including ophthalmology and neurology. Its proprietary platform is based on technology developed in the Muir Lab at Princeton University after more than 20 years of pioneering intein, protein splicing, and protein engineering research.
Founded in 2020, SpliceBio has rapidly established itself as a leader in the field. In 2022, the company raised a $57M series A financing – the largest in the history of Spanish biotechnology – led by UCB Ventures, Ysios Capital, NEA, Novartis Venture Fund, Gilde Healthcare and Asabys. This milestone was followed in 2023 by a strategic partnership with Spark Therapeutics (Roche) to develop a novel gene therapy for an undisclosed inherited retinal disorder. In 2024, the FDA granted IND clearance for SpliceBio’s lead program, SB-007, in Stargardt disease.
SpliceBio's international team operates from offices and labs in Barcelona (Parque Científico de Barcelona).
SCOPE
The Scientist in Analytical Development will play a critical role in the development and implementation of analytical methods to ensure the quality, safety, and efficacy of AAV-based gene therapies. The successful candidate will work collaboratively within both CMC and Translational functions by developing and validating assays for product development and regulatory submissions.
KEY RESPONSIBILITIES
Experimental Design and Execution :
Develop, optimize, and validate analytical methods across CMC and Translational projects including :
Data Analysis, conclusion and reporting :
Collaboration and Project Support :
QUALIFICATIONS
At Splice Bio, you will be part of a dynamic team dedicated to making a meaningful impact in the lives of patients with rare diseases. We offer a collaborative and inclusive environment where innovation is encouraged, and your contributions will make a direct impact on the success and growth of the company. We also offer competitive compensation, comprehensive benefits, and opportunities for professional growth in an expanding field.